Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

Obesity has a major impact on health and its economic cost could be up €1. 5 billion a year, according to HSE figures ...

While it may seem strange that politics could impact the price of popular weight loss drugs, it is a definite possibility.

The remarkable efficacy of new diabetes and weight loss medicines like Ozempic and Mounjaro have been ... In South Africa, these medicines remain largely inaccessible given their high costs, despite ...

Ozempic, Wegovy, Saxenda, Trulicity: These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for fo ...

Hannah's doctor prescribed Saxenda - part of ... the drug to be useful for weight loss, six months on, she's more than willing to keep paying the $80-per-week cost. And it's all because of ...

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

As a result, it will be available only on private prescription at a cost of €215 or more a month. That equates to an annual ...

A Department of Health and Social Care spokesperson said: “Obesity is debilitating, costs lives ... And Saxenda is the least effective, with five per cent weight loss, on average.